// App-Quantinova.ai

: Prognostic impact and major determinants of physical activity level in a real-life SCAD population: insights from the CLARIFY registry

Researchers

Presenter

  • S Biscaglia

Principal Investigators

  • G Campo

  • E Sorbets

  • I Ford

  • K M Fox

  • N Greenlaw

  • O Parkhomenko

  • J C Tardif

  • L Tavazzi

  • M Tendera

Medical Centers

  • University of Ferrara, Dept. of Medical Sciences, Ferrara, Italy

  • Hôpital Avicenne, Assistance Publique Hôpitaux de Paris & Université Paris 13, Bobigny France, Paris, France

  • University of Glasgow, Glasgow, United Kingdom

  • Imperial College London, Institute of Cardiovascular Medicine and Science, London, United Kingdom

  • Institute of cardiology, Kiev, Ukraine

  • University of Montreal, Montreal Heart Institute, Montreal, Canada

  • Maria Cecilia Hospital, Cotignola, Italy

Locations

  • Italy

  • France

  • United Kingdom

  • Canada

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved